These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36017597)

  • 21. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
    Parums DV
    Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3.
    Huang M; Wu L; Zheng A; Xie Y; He Q; Rong X; Han P; Du P; Han P; Zhang Z; Zhao R; Jia Y; Li L; Bai B; Hu Z; Hu S; Niu S; Hu Y; Liu H; Liu B; Cui K; Li W; Zhao X; Liu K; Qi J; Wang Q; Gao GF
    Immunity; 2022 Aug; 55(8):1501-1514.e3. PubMed ID: 35777362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022.
    Björk J; Bonander C; Moghaddassi M; Rasmussen M; Malmqvist U; Inghammar M; Kahn F
    Euro Surveill; 2022 May; 27(18):. PubMed ID: 35514304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of the Omicron SARS-CoV-2 Lineage and Its BA.1 Variant with Multiplex RT-qPCR.
    Yolshin ND; Komissarov AB; Varchenko KV; Musaeva TD; Fadeev AV; Lioznov DA
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends.
    Farahat RA; Abdelaal A; Umar TP; El-Sakka AA; Benmelouka AY; Albakri K; Ali I; Al-Ahdal T; Abdelazeem B; Sah R; Rodriguez-Morales AJ
    Infez Med; 2022; 30(4):480-494. PubMed ID: 36482957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
    Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
    Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021.
    Subramoney K; Mtileni N; Bharuthram A; Davis A; Kalenga B; Rikhotso M; Maphahlele M; Giandhari J; Naidoo Y; Pillay S; Ramphal U; Ramphal Y; Tegally H; Wilkinson E; Mohale T; Ismail A; Mashishi B; Mbenenge N; de Oliveira T; Makatini Z; Fielding BC; Treurnicht FK;
    J Med Virol; 2022 Aug; 94(8):3676-3684. PubMed ID: 35441368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases.
    Lentini A; Pereira A; Winqvist O; Reinius B
    Med; 2022 Sep; 3(9):636-643.e4. PubMed ID: 35981541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study.
    Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
    Clin Microbiol Infect; 2023 Jan; 29(1):101-106. PubMed ID: 36028091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection.
    Jeong HW; Kim SM; Jung MK; Noh JY; Yoo JS; Kim EH; Kim YI; Yu K; Jang SG; Gil J; Casel MA; Rare R; Choi JH; Kim HS; Kim JH; Um J; Kim C; Kim Y; Chin BS; Jung S; Choi JY; Song KH; Kim YD; Park JS; Song JY; Shin EC; Choi YK
    Cell Rep Med; 2022 Oct; 3(10):100764. PubMed ID: 36182684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022.
    Sievers C; Zacher B; Ullrich A; Huska M; Fuchs S; Buda S; Haas W; Diercke M; An der Heiden M; Kröger S
    Euro Surveill; 2022 Jun; 27(22):. PubMed ID: 35656831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.
    Zaballa ME; Perez-Saez J; de Mestral C; Pullen N; Lamour J; Turelli P; Raclot C; Baysson H; Pennacchio F; Villers J; Duc J; Richard V; Dumont R; Semaani C; Loizeau AJ; Graindorge C; Lorthe E; Balavoine JF; Pittet D; Schibler M; Vuilleumier N; Chappuis F; Kherad O; Azman AS; Posfay-Barbe KM; Kaiser L; Trono D; Stringhini S; Guessous I;
    Lancet Reg Health Eur; 2023 Jan; 24():100547. PubMed ID: 36474728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.
    Wang Y; Long Y; Wang F; Li C; Liu W
    Int J Med Sci; 2023; 20(1):151-162. PubMed ID: 36619228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
    Xia S; Wang L; Zhu Y; Lu L; Jiang S
    Signal Transduct Target Ther; 2022 Jul; 7(1):241. PubMed ID: 35853878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-Vaccination Neutralization Responses to Omicron Sub-Variants.
    Jacobsen H; Katzmarzyk M; Higdon MM; Jiménez VC; Sitaras I; Bar-Zeev N; Knoll MD
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Clinical Presentations of Omicron Infections with the Lineages BA.2 and BA.5 in Mecklenburg-Western Pomerania, Germany, between April and July 2022.
    Goller KV; Moritz J; Ziemann J; Kohler C; Becker K; Hübner NO; The CoMV-Gen Study Group
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
    Britton A; Embi PJ; Levy ME; Gaglani M; DeSilva MB; Dixon BE; Dascomb K; Patel P; Schrader KE; Klein NP; Ong TC; Natarajan K; Hartmann E; Kharbanda AB; Irving SA; Dickerson M; Dunne MM; Raiyani C; Grannis SJ; Stenehjem E; Zerbo O; Rao S; Han J; Sloan-Aagard C; Griggs EP; Weber ZA; Murthy K; Fadel WF; Grisel N; McEvoy C; Lewis N; Barron MA; Nanez J; Reese SE; Mamawala M; Valvi NR; Arndorfer J; Goddard K; Yang DH; Fireman B; Ball SW; Link-Gelles R; Naleway AL; Tenforde MW
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(42):1335-1342. PubMed ID: 36264840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convolutional Neural Networks Based on Sequential Spike Predict the High Human Adaptation of SARS-CoV-2 Omicron Variants.
    Nan BG; Zhang S; Li YC; Kang XP; Chen YH; Li L; Jiang T; Li J
    Viruses; 2022 May; 14(5):. PubMed ID: 35632811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.
    Khan K; Karim F; Ganga Y; Bernstein M; Jule Z; Reedoy K; Cele S; Lustig G; Amoako D; Wolter N; Samsunder N; Sivro A; San JE; Giandhari J; Tegally H; Pillay S; Naidoo Y; Mazibuko M; Miya Y; Ngcobo N; Manickchund N; Magula N; Karim QA; von Gottberg A; Abdool Karim SS; Hanekom W; Gosnell BI; ; Lessells RJ; de Oliveira T; Moosa MS; Sigal A
    Nat Commun; 2022 Aug; 13(1):4686. PubMed ID: 35948557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
    Link-Gelles R; Levy ME; Gaglani M; Irving SA; Stockwell M; Dascomb K; DeSilva MB; Reese SE; Liao IC; Ong TC; Grannis SJ; McEvoy C; Patel P; Klein NP; Hartmann E; Stenehjem E; Natarajan K; Naleway AL; Murthy K; Rao S; Dixon BE; Kharbanda AB; Akinseye A; Dickerson M; Lewis N; Grisel N; Han J; Barron MA; Fadel WF; Dunne MM; Goddard K; Arndorfer J; Konatham D; Valvi NR; Currey JC; Fireman B; Raiyani C; Zerbo O; Sloan-Aagard C; Ball SW; Thompson MG; Tenforde MW
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(29):931-939. PubMed ID: 35862287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.